Nicholas Murray, 26, will receive $8 billion from lawsuit claiming growth of breasts after taking medication manufactured by Johnson & Johnson, according to the New York Post. The medication known as Risperdal is an off-label brand that has resulted in over 13,000 lawsuits from individuals who claim that the drug caused a condition called gynecomastia in males which involves the enlargement of breast tissue.
Murray won a similar claim against the pharmaceutical giant in 2015 in the amount of $1.75 million, which was later reduced by the state appeals court. “Johnson & Johnson chose billions over children,” claimed the jury members who resided over Murray’s prior case. The $8 billion awarded Murray in his latest case was the largest amount ever awarded in any Johnson & Johnson lawsuit. “The purpose of the $8 billion figure was merely to send a message,” stated University of Richmond School of Law professor, Carl. Tobias.